Fluidigm is launching a number of mass cytometry products in the third quarter. Three Imaging Mass Cytometry Maxpar panel kits are designed for immune-oncology research. Developed using pathologist-verified antibodies, the panels can be mixed and matched to profile tumor-infiltrating lymphocytes, immune cell activation states, and tissue architecture. By combining them as a single 18-marker panel, researchers can broadly profile activated tumor-infiltrating lymphocytes for single-cell analysis of tumor architecture from a single tissue scan, Fluidigm said.
In addition, Fluidigm will introduce new CyTOF software, designed to be used with the Hyperion Imaging System for cellular biomarker identification. According to the firm, the software streamlines the selection and acquisition of multiple regions of interest (ROI) from each slide. Researchers can remotely annotate those ROIs using brightfield reference images to guide automated batch acquisition of highly multiplexed images at 1-micron resolution. During image acquisition, researchers can visualize multiplexed images in real time across all detection channels to ensure data quality, Fluidigm said.
Finally, the company will introduce seven new cadmium metal labeling kits for mass cytometry. The isotopes are the first of a new series in development and will allow researchers to design and customize larger panels to advance biomarker discovery and therapeutic development, Fluidigm said.